Factors Associated with Hemoglobin in Acute Kidney Injury: Differences between Survivors and Deceased Patients
Keywords:
kidney injury; mortality; hemoglobin; nephrology; multivariate analysisAbstract
Introduction: Acute kidney injury (AKI) is associated with high morbidity and mortality, frequently accompanied by anemia as a secondary complication.
Objective: To determine factors associated with minimum hemoglobin at 14 days in patients with acute kidney injury, differentiating between survivors and deceased.
Methods: Longitudinal study of a secondary database of hospitalized patients with Acute kidney injury. Clinical and biochemical variables were analyzed using multivariate linear regression to identify factors associated with minimum hemoglobin at 14 days. The analysis was stratified according to survival. Standardized coefficients (β), Spearman correlation and Student's t test were used.
Results: The regression model showed good fit in both survivors and deceased patients. In survivors, baseline hemoglobin was the strongest predictor, along with length of hospitalization and bicarbonate levels. In the diseased, age and days of hospitalization were significant. In the correlation analysis, day-14 hemoglobin in survivors was mainly associated with diastolic blood pressure and bicarbonate, whereas in the deceased it showed a negative correlation with the days of hospitalization.
Conclusions: Multivariate regression analysis identified key predictors of hemoglobin decline in patients with acute kidney injury. Differences in predictive factors between survivors and deceased suggest distinct pathophysiological mechanisms.
Downloads
References
1. Gaut JP, Liapis H. Acute kidney injury pathology and pathophysiology: a retrospective review. Clin Kidney J. 2020;14(2):526-36. DOI: 10.1093/ckj/sfaa142.
2. Goyal A, Daneshpajouhnejad P, Hashmi MF, et al. Acute kidney injury [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [citado 17/02/2025]. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK441896/
3. Gameiro J, Marques F, Lopes JA. Long-term consequences of acute kidney injury: a narrative review. Clin Kidney J. 2020;14(3):789-804. DOI: 10.1093/ckj/sfaa177.
4. Portolés J, Martín L, Broseta JJ, et al. Anemia in chronic kidney disease: From pathophysiology and current treatments, to future agents. Front Med (Lausanne). 2021;8:642296. DOI: 10.3389/fmed.2021.642296.
5. Aoun M, Sleilaty G, Boueri C, et al. Erythropoietin in Acute Kidney Injury (EAKI): a pragmatic randomized clinical trial. BMC Nephrol. 2022;23(1):100. DOI: 10.1186/s12882-022-02727-5.
6. Wilson F. Automated, medication-targeted alerts for Acute Kidney Injury – A randomized trial. California: Dryad; 2023. DOI: 10.5061/DRYAD.KH189327P.
7. Wilson FP, Yamamoto Y, Martin M, et al. A randomized clinical trial assessing the effect of automated medication-targeted alerts on acute kidney injury outcomes. Nat Commun. 2023;14(1):2826. DOI: 10.1038/s41467-023-38532-3.
8. Hoste EA, Bagshaw SM, Bellomo R, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015;41(8):1411-23. DOI: 10.1007/s00134-015-3934-7.
9. Benchimol EI, Smeeth L, Guttmann A, et al. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) Statement. PLoS Med [Internet]. 2015 [citado 29/05/2024];12(10):e1001885. Disponible en: https://www.equator-network.org/reporting-guidelines/record/
10. Creative Commons. CC0 1.0 Universal [Internet]. California: Creative Commons; 2010 [citado 24/02/2026]. Disponible en: https://creativecommons.org/publicdomain/zero/1.0/
11. Li P, Chen M, Huang Y, et al. Prognostic impact of in-hospital hemoglobin decline in non-overt bleeding ICU patients with acute myocardial infarction. BMC Cardiovasc Disord. 2023;23(1):231. DOI: 10.1186/s12872-023-03251-6.
12. Correa Guerrero J, Rico Fontalvo J, Daza Arnedo R, et al. Acid-base imbalance: a review with proposed unified diagnostic algorithm. Rev Colom Nefrol. 2020;7(2):85-97. DOI: 10.22265/acnef.7.2.497.
13. Canny SP, Orozco SL, Thulin NK, et al. Immune mechanisms in inflammatory anemia. Annu Rev Immunol. 2023;41(1):405-29. DOI: 10.1146/annurev-immunol-101320-125839.
14. Badura K, Janc J, Wąsik J, et al. Anemia of chronic kidney disease—A narrative review of its pathophysiology, diagnosis, and management. Biomedicines. 2024;12(6):1191. DOI: 10.3390/biomedicines12061191.
15. Sheng S, Li A, Zhang C, et al. Association between hemoglobin and in-hospital mortality in critically ill patients with sepsis: evidence from two large databases. BMC Infect Dis. 2024;24(1):1450. DOI: 10.1186/s12879-024-10335-x.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Alberto Guevara-Tirado
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All content published in this journal is Open Access, distributed under the terms of the CC BY-NC 4.0 License.
It allows:
- Copy and redistribute published material in any medium or format.
- Adapt the content.
This will be done under the following terms:
- Attribute the authors' credits and indicate whether changes were made, in which case it must be in a reasonable way.
- Non-commercial use.
- Recognize the journal where it is published.
The copyrights of each article are maintained, without restrictions.
